Human NF1-mutant melanomas have the worst outcome among all metastatic melanomas [8], and PTEN-mutant melanomas are known to be resistant to T-cell mediated immunotherapy such as the immune checkpoint inhibitor [25]. This evidence concerns the gene PTEN and metastatic melanoma.